POLYURETHANE FOAM COMPOSITION

Abstract

The invention relates to a polyurethane composition, which is used for the manufacture of products for the industry and households, in particular in the manufacturing of mattresses, sofas, seats, chairs, and underwear. The polyurethane foam composition, according to the invention consists of polyol, organic polyisocyanate, catalyst, foaming agent, polymerization initiator, stabilizer, additives, and contains powdered amber or powdered amber resin with particle size within the range of microns. The composition provides versatile application, possessing properties beneficial to health, such as stimulating metabolism, relieving asthmatic and allergic respiratory problems, helping the overcoming of physical pain, and eliminating negative energy.

Claims

1. A polyurethane foam product based on polyol, organic polyisocyanate, catalyst, foaming agent, polymerization initiator, stabilizer and additives, characterized by that it contains powdered amber or powdered amber resin with particle size within the range of microns.

2. Composition, according to claim 1, characterized in that the particle size is within the range of 1 to 3000.

3. Composition, according to claim 1, characterized in that the powdered amber or powdered amber resin is in an amount of 0.1 to 10% by weight.

4. Use of the composition, according to claim 1 in production of a mattress, pillow, blanket, or any other product of similar function.

Description

EXAMPLES OF THE PREFERRED EMBODIMENTS OF THE INVENTION

[0015] The current invention is illustrated by the following exemplary embodiments:

Example 1

[0016] Polyurethane foam was prepared by using the following starting components:

[0017] All raw materials for the preparation of the polyurethane foam are tempered at

TABLE-US-00001 Quantity in weight Starting components parts/kg Polyether polyol triol with a hydroxyl number 56 100 and molecular mass 3000 g/mol Toluene 2,4- diisocyanate and Toluene 2,6- 60 diisocyanate in a ratio of 80:20 Water 5 Tin (II) - 2-ethylhexanoate 0.37 Triethylenediamine in dipropylene 0.236 Silicone 1.20 Pigment 0.05
a temperature of 25 C. In a mixer equipped with a stirrer, were dosed the necessary amounts of the polyether polyol triol, water, tin (II)-2-ethylhexanoate, triethylenediamine in dipropylene glycol, silicon, and pigment. To the homogenized mixture in the mixer it was dosed additionally 2 parts by weight/kg powdered amber with particle size of 70, after which was added the tempered at a temperature of 25 C. mixture of toluene 2,4-diisocyanate and toluene 2,6-diisocyanate in a ratio of 80:20, which starts the reaction for the preparation of polyurethane foam. The mixture is dispensed into a mold which is placed in a vacuum chamber where it expands for 70 s under vacuum 18 kPa, and then the expansion continues for 30 s at atmospheric pressure.

Example 2

[0018] Polyurethane foam was prepared by using the following starting components:

TABLE-US-00002 Quantity in parts by Starting components weight/kg Polyether polyol triol with hydroxyl number 56 70 and molecular mass of 3000 g/mol Polyether polymer polyol based on glycerol, 30 propylene oxide, ethylene oxide (from 50.00 to 60.00%) with a copolymer of styrene with acrylonitrile (from 40.00 to 50.00%) with hydroxyl number 28 Toluene 2.4 diisocyanate and toluene 2.6 41.7 diisocyanate in a ratio of 80:20 Water 3.0 Tin (II)- 2-ethylhexanoate 0.18 Triethylenamine in dipropyleneglycol 0.20 Silicone 1.00 Pigment 0.05

[0019] The raw materials for the preparation of the polyurethane foam were tempered at a temperature of 25 C. and mixed according to the method described in Example 1. To the mixture was added powdered amber with particle size of 70 in an amount of 4 parts by weight/kg.

[0020] The resulting mixture was dosed into a mold and the expansion took place in a vacuum chamber in which vacuum 67 kPa for 100 s is maintained, and then it continued at atmospheric pressure for 90 s.

[0021] The resulting polyurethane foam had a volume weight (density) of 302 kg/m.sup.3; hardness 4.01 kPa, and elasticity 42% according to the Ball rebound test.

Example 3

[0022] Polyurethane foam was prepared by using the following starting components:

TABLE-US-00003 Quantity in parts by Starting components weight/kg Polyether polyol triol with hydroxyl number 56 65 and molecular mass of 3000 g/mol Polyether polymer polyol based on glycerol, 30 propylene oxide, ethylene oxide (from 50.00 to 60.00%) with copolymer of styrene with acrylonitrile (from 40.00 to 50.00%) with hydroxyl number 28 Polyether polyol based on glycerol, propylene 5 oxide, ethylene oxide with 75% content of ethylene oxide highly effective, (Cell Opener), hydroxyl number 33 Toluene- 2,4- diisocyanate and toluene- 2,6- 45.8 diisocyanate in a ratio of 80:20 Water 3.5 Tin (II)- 2-ethylhexanoate 0.28 Triethylenamine in dipropyleneglycol 0.12 Silicone 0.78 Pigment 0.05

[0023] The raw materials for the preparation of the polyurethane foam were tempered and mixed according to the method described in Example 1. To achieve the desired health effect of the impact on the user, to the mixture was added powdered amber with particle size of 70 in an amount of 2.7 parts by weight/kg.

[0024] The resulting mixture of raw materials was dosed into a mold and expanded at atmospheric pressure.

[0025] The resulting polyurethane foam had a volume weight of 362 kg/m.sup.3 and hardness 21 kPa.

Example 4

[0026] Polyurethane foam was prepared by using the following starting components:

TABLE-US-00004 Quantity in parts by Starting components weight/kg Polyether polyol triol with hydroxyl number 56 and 5 molecular mass of 3000 g/mol Polyether polyol based on glycerol, propylene oxide 90 with hydroxyl number 241.9 and molecular weight of 755 g/mol Polyether polyol based on glycerol, propylene oxide, 5 ethylene oxide with content of ethylene oxide 75% highly effective (Cell Opener) Toluene 2.4 diisocyanate and toluene 2.6 27 diisocyanate in a ratio of 80:20 Water 1.0 Tin (II)- 2-ethylhexanoate 0.009 Triethylenamine in dipropyleneglycol 0.46 Silicone 0.45 Pigment 0.05

[0027] The raw materials for the preparation of the polyurethane foam were tempered and mixed according to the method described in Example 1. In order to achieve the desired health effect of the impact on the user, to the mixture was added powdered amber with particle size of 70 in an amount of 6 parts by weight/kg.

[0028] The resulting mixture of raw materials was dosed into a mold and expanded at atmospheric pressure.

[0029] The resulting polyurethane foam had a volume weight of 802 kg/m.sup.3 and hardness 2.01 kPa.

Example 5

[0030] Amber powder with a particle size of any value in the range of 1 to 170 was mixed with appropriate glue. The mixture was stirred by means of a double diaphragm pump with complete recirculation until reaching homogeneous mixture. The resulting mixture was sprayed in the shaped polyurethane product by pistol model Finex.

[0031] FIG. 1 depicts a scheme of a mattress made of the polyurethane foam composition, filled with natural amber powder according to the invention and used for disease prevention, health enhancing treatment and therapy of common disorders. The amber mattress as in FIG. 1 consists of: arranged spring unit (4), covered by layer of a fabric material ((3), which is covered by the mattress cover quilted with polyurethane foam, containing natural amber powder (1) wherein the appropriate shape was provided by the mattress tape (2) positioned along the top and bottom edges of the mattress. FIG. 1 provides the overview of a mattress (1) for a person to lie on the back and perform prevention/healing treatment via the back area. Nevertheless, the same ideas, principles and knowledge may be applied to create a variety of other active products with natural amber e.g. a pillow, blanket, belt, band, etc.

[0032] FIG. 2 depicts a scheme of a mattress made of polyurethane foam composition, filled with natural amber powder according to the invention and used for disease prevention, health enhancing treatment and therapy of common disorders. The mattress as in FIG. 2 consists of shaped polyurethane foam (5), and upon which foam layer (5a), containing natural amber powder, according to the invention, covered by mattress cover quilted with fiber (6) provided by zipper along the middle part of all side walls.

[0033] FIG. 3 provides the overview scheme of a mattress, composed of core of polyurethane foam (7) covered by mattress cover quilted with fiber (6) provided by zipper along all side walls.

[0034] FIG. 4 depicts an active pillow made of the polyurethane foam composition with natural amber powder, according to the invention to put close to the human's body (for a person to lie on/put his head on) and perform preventive treatment, health enhancing treatment and therapy of common disorders. For example, in this case, the product (the pillow) is intended to be used for everyday preventive/healing process. The pillow according to the FIG. 4 consists of a shaped polyurethane foam (5), containing natural amber powder, according to the invention, covered by a pillow fabric cover (8)

[0035] The essence of the invention is the product (a structure) that combines: [0036] the property of natural amber to radiate ions that positively influence a human's organism; [0037] ability of a human (living organism) to induce a field around amber with his own biological field, where the human (or the animal) positively responds to the effect of electromagnetic field (including other components, if any) created around amber; [0038] The designed product (a mattress, pillow, blanket,) is very comfortable and safe, relatively soft, can be of any shape, can be used in sitting, semi-lying and lying, as well as side-lying position etc.

[0039] The essential uniqueness of the invention: [0040] the product contains natural amber; [0041] natural amber used in the product may actively heated by the body temperature, only; [0042] the product is easy to use and affordable: [0043] does not require any special storage condition; [0044] lightweight; [0045] relatively inexpensive; [0046] does not smell (compared with other amber product of the same order); [0047] the therapy procedure can be performed at home, in a calm environment and at a convenient time; [0048] safe to use; In order to illustrate and describe the invention, description of the most preferred embodiment options is provided hereinabove. This invention does not require particular steps to be detailed performed and does not limit a claim to a particular structure or scope. The above description shall be regarded as an illustration rather than a limitation. It is apparent that specialists in the field may be well aware of multiple possible modifications and variations. The described embodiments have been selected and described with the aim to assist the specialists in the field in exploring the principles of the invention and its practical application using various modifications for particular use or embodiment, as quantitative parameters of the product and its application may be different depending on the particular use. It has been anticipated that the scope of invention is defined by the enclosed claim and its equivalents containing the terms that are used in the widest scope of meaning, unless stated otherwise. It has been acknowledged that embodiments described, may provide amendments that do not deviate from the scope of the invention as stated in the claim hereinafter.